Has Samuel Poser, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,357 in general payments to Samuel Poser, MD across 485 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Samuel Poser, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Samuel Poser, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Samuel Poser, MD

Internal Medicine · Columbus, WINPI 1346243821

Payments from drug & device makers

$7,357in general payments, 2019–2025

Across 485 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$1K
Johnson & Johnson$828
AstraZeneca$763
AbbVie$580
Novo Nordisk$546
Astellas Pharma US Inc$469
plus $3K from 37 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	87	$1,013
Johnson & Johnson(2 entities)	58	$828
AstraZeneca	39	$763
AbbVie(2 entities)	48	$580
Novo Nordisk	36	$546
Astellas Pharma US Inc	15	$469
Lilly USA, LLC	35	$435
Boehringer Ingelheim	23	$388
Dexcom, Inc.	16	$313
Amgen	16	$266
E.r. Squibb & Sons, L.L.C.	11	$184
GSK	15	$162
Biohaven Pharmaceuticals, Inc.	6	$130
Sunovion Pharmaceuticals Inc.	9	$104
Novartis	6	$87
Aimmune Therapeutics, Inc.	4	$82
Nestle Healthcare Nutrition Inc.	6	$80
Merck	6	$79
Melinta Therapeutics, LLC	4	$77
Smith+Nephew	1	$58
Mylan Specialty L.p.	3	$51
Amarin Pharma, Inc.	3	$50
Abbott	2	$46
Bridgebio Pharma, Inc.	3	$46
Neurelis, Inc.	2	$44
Scilex Pharmaceuticals Inc.	3	$43
Hologic Sales And Service, LLC	3	$43
Edwards Lifesciences	2	$42
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$40
Lexicon Pharmaceuticals, Inc.	2	$37
Sumitomo Pharma America, Inc.	2	$36
Exact Sciences	2	$36
Biogen	2	$29
Sanofi-aventis U.S. LLC	2	$27
Teva Pharmaceuticals USA, Inc.	2	$25
Idorsia Pharmaceuticals US Inc	1	$22
Daiichi Sankyo Inc.	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	2	$17
GE HealthCare	1	$15
Esperion Therapeutics, Inc.	1	$13
Biohaven Pharmaceutical Holding Company Ltd.	1	$12
Bayer	1	$12
Kowa Pharmaceuticals America, Inc.	1	$11

How this compares

$7,357 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.

See all internal medicine providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$128,647

Medicare patients

482

Services billed

3,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Columbus

Nicholas SiebersMadison$47.3M
Irene MirkinMiddleton$42.9M
John BlanchardMadison$17.2M
Carlos SanabriaWest Bend$12.9M
Andrew KimWauwatosa$2.3M
Jeremiah DeptaMilwaukee$2.2M
Gilbert JenouriMilwaukee$2.2M
Stephen FlachMadison$1.6M
Aliaksandr TrusauGreen Bay$1.5M
Samuel IdarragaWauwatosa$743K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →